SELECT
Evaluation of cardiovascular outcomes with semaglutide in patients with overweight or obesity and prior MI/stroke
- Stage
- klaar
- Medicine
- semaglutide
- Population
- ASCVD
- Phase
- III
- First Patient In
- 19 February 2019
- Last Patient In
- 17 March 2021
- Last Patient Last Visit
- 21 June 2023
National Lead
dr. A. van Beek
Office Contact
